The predictors of 3-and 30-day mortality in 660 MERS-CoV patients

被引:67
作者
Ahmed, Anwar E. [1 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Publ Hlth & Hlth Informat, Riyadh, Saudi Arabia
来源
BMC INFECTIOUS DISEASES | 2017年 / 17卷
关键词
Mortality; MERS-CoV; Elderly; Camels; Saudi Arabia; RESPIRATORY SYNDROME CORONAVIRUS; SAUDI-ARABIA; SEVERE DISEASE; INFECTION; DEATH;
D O I
10.1186/s12879-017-2712-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The mortality rate of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) patients is a major challenge in all healthcare systems worldwide. Because the MERS-CoV risk-standardized mortality rates are currently unavailable in the literature, the author concentrated on developing a method to estimate the risk-standardized mortality rates using MERS-CoV 3- and 30-day mortality measures. Methods: MERS-CoV data in Saudi Arabia is publicly reported and made available through the Saudi Ministry of Health (SMOH) website. The author studied 660 MERS-CoV patients who were reported by the SMOH between December 2, 2014 and November 12, 2016. The data gathered contained basic demographic information (age, gender, and nationality), healthcare worker, source of infection, pre-existing illness, symptomatic, severity of illness, and regions in Saudi Arabia. The status and date of mortality were also reported. Cox-proportional hazard (CPH) models were applied to estimate the hazard ratios for the predictors of 3- and 30-day mortality. Results: 3-day, 30-day, and overall mortality were found to be 13.8%, 28.3%, and 29.8%, respectively. According to CPH, multivariate predictors of 3-day mortality were elderly, non-healthcare workers, illness severity, and hospital-acquired infections (adjusted hazard ratio (aHR) = 1.7; 8.8; 6.5; and 2.8, respectively). Multivariate predictors of 30-day mortality were elderly, non-healthcare workers, pre-existing illness, severity of illness, and hospital-acquired infections (aHR = 1.7; 19.2; 2.1; 3.7; and 2.9, respectively). Conclusions: Several factors were identified that could influence mortality outcomes at 3 days and 30 days, including age (elderly), non-healthcare workers, severity of illness, and hospital-acquired infections. The findings can serve as a guide for healthcare practitioners by appropriately identifying and managing potential patients at high risk of death.
引用
收藏
页数:8
相关论文
共 22 条
  • [1] Diagnostic delays in 537 symptomatic cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia
    Ahmed, Anwar E.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 62 : 47 - 51
  • [2] Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia
    Al Ghamdi, Mohammed
    Alghamdi, Khalid M.
    Ghandoora, Yasmeen
    Alzahrani, Ameera
    Salah, Fatmah
    Alsulami, Abdulmoatani
    Bawayan, Mayada F.
    Vaidya, Dhananjay
    Perl, Trish M.
    Sood, Geeta
    [J]. BMC INFECTIOUS DISEASES, 2016, 16
  • [3] Al-Abdallat MM, 2014, CLIN INFECT DIS, V14
  • [4] Building predictive models for MERS-CoV infections using data mining techniques
    Al-Turaiki, Isra
    Alshahrani, Mona
    Almutairi, Tahani
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2016, 9 (06) : 744 - 748
  • [5] Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients
    Almekhlafi, Ghaleb A.
    Albarrak, Mohammed M.
    Mandourah, Yasser
    Hassan, Sahar
    Alwan, Abid
    Abudayah, Abdullah
    Altayyar, Sultan
    Mustafa, Mohamed
    Aldaghestani, Tareef
    Alghamedi, Adnan
    Talag, Ali
    Malik, Muhammad K.
    Omrani, Ali S.
    Sakr, Yasser
    [J]. CRITICAL CARE, 2016, 20
  • [6] Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital
    Alraddadi, Basem
    Bawareth, Noha
    Omar, Haneen
    Alsalmi, Hanadi
    Alshukairi, Abeer
    Qushmaq, Ismael
    Feteih, Maun
    Qutob, Mohammed
    Wali, Ghassan
    Khalid, Imran
    [J]. ANNALS OF THORACIC MEDICINE, 2016, 11 (02) : 128 - 131
  • [7] [Anonymous], ARCH VIROL
  • [8] Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
    Assiri, Abdullah
    Al-Tawfiq, Jaffar A.
    Al-Rabeeah, Abdullah A.
    Al-Rabiah, Fahad A.
    Al-Hajjar, Sami
    Al-Barrak, Ali
    Flemban, Hesham
    Al-Nassir, Wafa N.
    Balkhy, Hanan H.
    Al-Hakeem, Rafat F.
    Makhdoom, Hatem Q.
    Zumla, Alimuddin I.
    Memish, Ziad A.
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (09) : 752 - 761
  • [9] Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia
    Banik, Gouri Rani
    Alqahtani, Amani Salem
    Booy, Robert
    Rashid, Harunor
    [J]. VIROLOGICA SINICA, 2016, 31 (01) : 81 - 84
  • [10] Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea
    Choi, Won Suk
    Kang, Cheol-In
    Kim, Yonjae
    Choi, Jae-Phil
    Joh, Joon Sung
    Shin, Hyoung-Shik
    Kim, Gayeon
    Peck, Kyong Ran
    Chung, Doo Ryeon
    Kim, Hye Ok
    Song, Sook Hee
    Kim, Yang Ree
    Sohn, Kyung Mok
    Jung, Younghee
    Bang, Ji Hwan
    Kim, Nam Joong
    Lee, Kkot Sil
    Jeong, Hye Won
    Rhee, Ji-Young
    Kim, Eu Suk
    Woo, Heungjeong
    Oh, Won Sup
    Huh, Kyungmin
    Lee, Young Hyun
    Song, Joon Young
    Lee, Jacob
    Lee, Chang-Seop
    Kim, Baek-Nam
    Choi, Young Hwa
    Jeong, Su Jin
    Lee, Jin-Soo
    Yoon, Ji Hyun
    Wi, Yu Mi
    Joung, Mi Kyong
    Park, Seong Yeon
    Lee, Sun Hee
    Jung, Sook-In
    Kim, Shin-Woo
    Lee, Jae Hoon
    Lee, Hyuck
    Ki, Hyun Kyun
    Kim, Yeon-Sook
    [J]. INFECTION AND CHEMOTHERAPY, 2016, 48 (02) : 118 - 126